questionsmedicales.fr
Régions géographiques
Amériques
Amérique centrale
Amérique centrale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Amérique centrale : Questions médicales les plus fréquentes",
"headline": "Amérique centrale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Amérique centrale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Amérique centrale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Amériques",
"url": "https://questionsmedicales.fr/mesh/D000569",
"about": {
"@type": "MedicalCondition",
"name": "Amériques",
"code": {
"@type": "MedicalCode",
"code": "D000569",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.107"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Belize",
"alternateName": "Belize",
"url": "https://questionsmedicales.fr/mesh/D001531",
"about": {
"@type": "MedicalCondition",
"name": "Belize",
"code": {
"@type": "MedicalCode",
"code": "D001531",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.107.169.133"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Costa Rica",
"alternateName": "Costa Rica",
"url": "https://questionsmedicales.fr/mesh/D003364",
"about": {
"@type": "MedicalCondition",
"name": "Costa Rica",
"code": {
"@type": "MedicalCode",
"code": "D003364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.107.169.238"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Salvador",
"alternateName": "El Salvador",
"url": "https://questionsmedicales.fr/mesh/D004544",
"about": {
"@type": "MedicalCondition",
"name": "Salvador",
"code": {
"@type": "MedicalCode",
"code": "D004544",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.107.169.339"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Guatemala",
"alternateName": "Guatemala",
"url": "https://questionsmedicales.fr/mesh/D006166",
"about": {
"@type": "MedicalCondition",
"name": "Guatemala",
"code": {
"@type": "MedicalCode",
"code": "D006166",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.107.169.454"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Honduras",
"alternateName": "Honduras",
"url": "https://questionsmedicales.fr/mesh/D006721",
"about": {
"@type": "MedicalCondition",
"name": "Honduras",
"code": {
"@type": "MedicalCode",
"code": "D006721",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.107.169.534"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nicaragua",
"alternateName": "Nicaragua",
"url": "https://questionsmedicales.fr/mesh/D009527",
"about": {
"@type": "MedicalCondition",
"name": "Nicaragua",
"code": {
"@type": "MedicalCode",
"code": "D009527",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.107.169.690"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Panama",
"alternateName": "Panama",
"url": "https://questionsmedicales.fr/mesh/D010176",
"about": {
"@type": "MedicalCondition",
"name": "Panama",
"code": {
"@type": "MedicalCode",
"code": "D010176",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.107.169.772"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Amérique centrale",
"alternateName": "Central America",
"code": {
"@type": "MedicalCode",
"code": "D002489",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dylan E Graetz",
"url": "https://questionsmedicales.fr/author/Dylan%20E%20Graetz",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee."
}
},
{
"@type": "Person",
"name": "Yichen Chen",
"url": "https://questionsmedicales.fr/author/Yichen%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee."
}
},
{
"@type": "Person",
"name": "Meenakshi Devidas",
"url": "https://questionsmedicales.fr/author/Meenakshi%20Devidas",
"affiliation": {
"@type": "Organization",
"name": "Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee."
}
},
{
"@type": "Person",
"name": "Federico Antillon-Klussmann",
"url": "https://questionsmedicales.fr/author/Federico%20Antillon-Klussmann",
"affiliation": {
"@type": "Organization",
"name": "National Unit of Pediatric Oncology, Francisco Marroquin University School of Medicine, Guatemala City, Guatemala."
}
},
{
"@type": "Person",
"name": "Ligia Fu",
"url": "https://questionsmedicales.fr/author/Ligia%20Fu",
"affiliation": {
"@type": "Organization",
"name": "Pediatric Hematology and Oncology Unit, Tegucigalpa School Hospital, Tegucigalpa, Honduras."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36268143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/6833078"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35997934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12013-022-01089-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "A rapid fluorescent aptasensor for point-of-care detection of C-reactive protein.",
"datePublished": "2022-06-04",
"url": "https://questionsmedicales.fr/article/35714415",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.talanta.2022.123661"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis.",
"datePublished": "2022-07-09",
"url": "https://questionsmedicales.fr/article/35821191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejim.2022.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.",
"datePublished": "2022-06-24",
"url": "https://questionsmedicales.fr/article/35766701",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1806-9282.20220236"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Amériques",
"item": "https://questionsmedicales.fr/mesh/D000569"
},
{
"@type": "ListItem",
"position": 4,
"name": "Amérique centrale",
"item": "https://questionsmedicales.fr/mesh/D002489"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Amérique centrale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Amérique centrale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Amérique centrale",
"description": "Comment diagnostiquer le paludisme en Amérique centrale ?\nQuels tests pour la dengue ?\nComment identifier la leptospirose ?\nQuels signes indiquent une infection parasitaire ?\nComment diagnostiquer le virus Zika ?",
"url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=C-Reactive+Protein&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Amérique centrale",
"description": "Quels sont les symptômes de la dengue ?\nQuels signes de la leptospirose ?\nQuels symptômes du paludisme ?\nComment reconnaître le virus Zika ?\nQuels symptômes d'une infection parasitaire ?",
"url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=C-Reactive+Protein&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Amérique centrale",
"description": "Comment prévenir la dengue ?\nQuelles mesures contre le paludisme ?\nComment éviter la leptospirose ?\nQuelles précautions pour le virus Zika ?\nComment prévenir les infections parasitaires ?",
"url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=C-Reactive+Protein&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Amérique centrale",
"description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la leptospirose ?\nComment traiter le virus Zika ?\nQuels médicaments pour infections parasitaires ?",
"url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=C-Reactive+Protein&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Amérique centrale",
"description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la leptospirose ?\nQuelles complications du virus Zika ?\nQuelles complications des infections parasitaires ?",
"url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=C-Reactive+Protein&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Amérique centrale",
"description": "Quels sont les facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la leptospirose ?\nQuels facteurs de risque pour le virus Zika ?\nQuels facteurs de risque pour les infections parasitaires ?",
"url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=C-Reactive+Protein&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le paludisme en Amérique centrale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter le parasite du paludisme."
}
},
{
"@type": "Question",
"name": "Quels tests pour la dengue ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et PCR sont utilisés pour confirmer une infection par le virus de la dengue."
}
},
{
"@type": "Question",
"name": "Comment identifier la leptospirose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic est établi par des tests sérologiques et l'historique d'exposition à l'eau contaminée."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection parasitaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la diarrhée, la fièvre et la fatigue peuvent indiquer une infection parasitaire."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer le virus Zika ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sanguins pour détecter le virus ou les anticorps."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la dengue ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs articulaires, éruptions cutanées et fatigue."
}
},
{
"@type": "Question",
"name": "Quels signes de la leptospirose ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, maux de tête, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels symptômes du paludisme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, sueurs, maux de tête et fatigue sont des symptômes typiques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître le virus Zika ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, éruptions cutanées, douleurs articulaires et conjonctivite."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection parasitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections parasitaires peuvent causer diarrhée, douleurs abdominales et fatigue."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures contre le paludisme ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires, des répulsifs et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Comment éviter la leptospirose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec des eaux potentiellement contaminées et porter des bottes."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour le virus Zika ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et éviter les zones à risque de moustiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections parasitaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer une bonne hygiène, laver les aliments et éviter l'eau contaminée."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter le paludisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le paludisme est traité avec des antipaludiques comme la chloroquine ou l'artémisinine."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la leptospirose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques comme la doxycycline sont utilisés pour traiter la leptospirose."
}
},
{
"@type": "Question",
"name": "Comment traiter le virus Zika ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour infections parasitaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiparasitaires comme le mébendazole ou l'albendazole sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure la dengue sévère, l'hémorragie et le choc."
}
},
{
"@type": "Question",
"name": "Quelles complications du paludisme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le paludisme peut entraîner des anémies, des troubles neurologiques et la mort."
}
},
{
"@type": "Question",
"name": "Quelles complications de la leptospirose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions rénales, hépatiques et des hémorragies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quelles complications du virus Zika ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le virus Zika peut causer des malformations congénitales et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quelles complications des infections parasitaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections parasitaires peuvent entraîner des malnutritions et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones tropicales, avoir des moustiques et des antécédents d'infection."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le paludisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones endémiques, ne pas utiliser de moustiquaires et voyager sans prévention."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la leptospirose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Travail en milieu rural, contact avec des eaux contaminées et absence de vaccination."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le virus Zika ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones à forte densité de moustiques et absence de protection lors de rapports."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les infections parasitaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conditions d'hygiène précaires, voyage dans des zones endémiques et consommation d'eau contaminée."
}
}
]
}
]
}
The prognostic role of CRP (C-reactive protein) in gynecological tumors has been previously reported in individual studies, but whether CRP can be used as a separate potential prognostic factor has no...
A systematic search was carried out to find the literature evaluating the predictive role of CRP in the prognosis of gynecological cancer patients. For the purpose of determining the relationship betw...
A total of 19 studies, including 4062 patients, were analyzed retrospectively. The FIGO stage was related to the CRP level (OR = 0.43, 95% CI: 0.19-1.00). Age, lymph node metastasis, and histological ...
CRP may be utilized as a prognostic indicator for a variety of gynecologic malignancies, including cervical cancer, ovarian cancer, endometrial cancer, and vulvar cancer....
The acute phase C-reactive protein (CRP) is mainly synthesized and secreted by the liver in a cytokine-mediated response to infection or inflammation and circulates as a pentamer (pCRP) in plasma. Rec...
In this paper, we report on a novel fluorescent aptasensor based on aptamers modified by both nitrogen-doped graphene quantum dots (N-GQDs) and gold nanoparticles (AuNPs) for the detection of C-reacti...
To evaluate the association between C-reactive protein (CRP) and 10-year risk of cardiovascular (CV) events using the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), b...
ERS-RA was calculated in 1,251 "Cardiovascular Obesity and Rheumatic Disease Study (CORDIS)" database patients [(age 60.4(9.3) years; 78% female; disease duration, 11.6(8) years; CDAI, 9(9); CRP, 6.8(...
The mean (SD) 10-year risk of CV events was 12.9% (10). After adjusting for the use of DMARDs and biologics, CRP concentrations were significantly associated with 10-year risk of CV events (coefficien...
In a large cohort of RA patients without previous cardiovascular events, a 20 mg/L increase in CRP concentrations was associated with a 1% increase in 10-year risk of CV events. This suggests that act...
Chronic hepatitis C (CHC) is one of the most important health problems affecting the significant rate of world population and it may lead to cirrhosis and hepatocellular carcinoma. C-reactive protein ...
Patients with CHC infection who visited outpatient and inpatient internal medicine clinics of our institution between January 2021 and December 2021 were enrolled to this retrospective study. CLR of t...
Median CLR of CHC and control subjects was 2.61 (5.13%) and 0.31 (0.37%), respectively. CLR of the CHC group was significantly increased compared to the CLR of the controls (p<0.001). There was a sign...
Increased CLR in patients with CHC may be an alarming finding of liver fibrosis, as CLR is associated with both CHC and hepatic fibrosis....
Life's Essential 8 (LE8) is a score that includes modifiable risk factors for cardiovascular disease. Four health behaviors (diet, physical activity, nicotine exposure and sleep health) and four healt...
We investigate the interactions between C-reactive protein (CRP) and new CRP-binding peptide materials using experimental (biological and physicochemical) methods with the support of theoretical simul...
To assess whether low-grade inflammation, measured by serum high-sensitivity C-reactive protein (hsCRP) levels, is associated with...
A retrospective study....
University-affiliated IVF center....
In the present study, 875 women of normal weight who underwent their first fresh embryo transfer (ET) cycles for IVF treatment were divided into three groups according to serum concentrations of hsCRP...
Serum from women undergoing IVF was collected on days 2-4 of a spontaneous menstrual cycle prior to the commencement of ovarian stimulation....
The IVF outcomes included implantation, biochemical pregnancy, clinical pregnancy, miscarriage and live birth rates....
The women were divided into three groups according to the baseline serum levels of hsCRP as follows: low hsCRP (<1 mg/L; n=517), medium hsCRP (1-3 mg/L; n= 270), high hsCRP (>3 mg/L; n=88). The matern...
Among women of normal weight undergoing their first IVF treatment, it was found that low-grade inflammation was associated with reduced clinical pregnancy and live birth rates following fresh ET cycle...
Interest in using bedside C-reactive protein (CRP) and ferritin levels to identify patients with hyperinflammatory sepsis who might benefit from anti-inflammatory therapies has piqued with the COVID-1...
A prospective, observational cohort study....
Children with sepsis and organ failure in nine pediatric intensive care units in the United States....
Two hundred and fifty-five children were enrolled. Five distinct clinical multi-trajectory groups were identified. Plasma CRP (mg/dL), ferritin (ng/mL), and 31 cytokine levels were measured at two tim...
Group 1 had normal CRP and ferritin levels ( n = 8; 0% mortality); Group 2 had high CRP levels that became normal, with normal ferritin levels throughout ( n = 80; 5% mortality); Group 3 had high ferr...
Bedside CRP and ferritin levels can be used together to distinguish groups of children with sepsis who have different systemic inflammation cytokine responses and mortality risks. These data suggest f...
Social relationships are an important driver of health, and inflammation has been proposed as a key neurobiological mechanism to explain this effect. Behavioral researchers have focused on social rela...